Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,671.00
(
0.22%
)
News Focus
News Focus

Replies to post #85356 on Biotech Values

Replies to #85356 on Biotech Values
icon url

read_this_n0w

10/23/09 6:09 PM

#85357 RE: read_this_n0w #85356

MYRX The Company expects to report interim results from the ongoing Phase 2 trial of Azixa in metastatic melanoma at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting in Boston in November 2009.